HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank Miedema Selected Research

HIV Infections (HIV Infection)

8/2008HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
7/2008Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.
7/2006Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia.
8/2005Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
8/2005Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
7/2005Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
3/2005Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
1/2005High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
6/2004Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma.
2/2003Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank Miedema Research Topics

Disease

14Infections
07/2008 - 02/2002
11HIV Infections (HIV Infection)
08/2008 - 11/2002
9Acquired Immunodeficiency Syndrome (AIDS)
11/2014 - 04/2002
6Disease Progression
11/2014 - 02/2006
3HIV Seropositivity
09/2007 - 06/2004
2Tuberculosis (Tuberculoses)
07/2006 - 07/2005
1Viremia
07/2008
1Atrophy
03/2008
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2006
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2006
1Asymptomatic Infections
11/2005
1Lymphopenia (Lymphocytopenia)
11/2005
1Visceral Leishmaniasis (Kala Azar)
11/2005
1Epstein-Barr Virus Infections
08/2005
1Neoplasms (Cancer)
08/2005
1Lymphoma (Lymphomas)
08/2005
1Coinfection
07/2005
1Periodontitis
04/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2002

Drug/Important Bio-Agent (IBA)

6EpitopesIBA
09/2011 - 06/2004
5HLA-B57 antigenIBA
11/2014 - 01/2005
3RNA (Ribonucleic Acid)IBA
08/2008 - 09/2007
3CytokinesIBA
07/2008 - 11/2005
3AntigensIBA
08/2007 - 08/2005
3DNA (Deoxyribonucleic Acid)IBA
05/2006 - 08/2002
2HLA-B Antigens (HLA-B)IBA
11/2014 - 09/2011
2Interleukin-2 (IL2)IBA
07/2008 - 02/2006
2Antiviral Agents (Antivirals)IBA
01/2006 - 08/2005
1HLA-A Antigens (HLA-A)IBA
11/2014
1AIDS VaccinesIBA
07/2008
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2008
1Growth Hormone (Somatotropin)IBA
03/2008
1HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2008
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2007
1Mitochondrial DNA (mtDNA)IBA
08/2007
1Tuberculin (PPD)IBA
07/2006
1Isoniazid (Ftivazide)FDA LinkGeneric
07/2006
1IonomycinIBA
11/2005
1leishmaninIBA
11/2005
1Epstein-Barr Virus Nuclear AntigensIBA
11/2005
1Interleukin-4 (Interleukin 4)IBA
11/2005
1Interferon-gamma (Interferon, gamma)IBA
11/2005
1ChemokinesIBA
07/2005
1Chemokine CCL5IBA
07/2005
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
07/2005
1Chemokine ReceptorsIBA
07/2005
1Chemokine CCL4IBA
07/2005
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
09/2004
1SmokeIBA
04/2004
1VaccinesIBA
05/2002
1p24-VLP vaccineIBA
05/2002
1InterferonsIBA
04/2002
1fas Receptor (CD95 Antigen)IBA
02/2002

Therapy/Procedure

7Highly Active Antiretroviral Therapy (HAART)
08/2008 - 11/2002
5Therapeutics
11/2007 - 02/2003
1Aftercare (After-Treatment)
08/2008
1Hematopoietic Stem Cell Transplantation
07/2006